LONDON (MarketWatch) -- Exane BNP-Paribas on Monday shuffled some of its ratings in the European pharmaceutical sector. The broker lowered German firm Bayer to neutral from outperform, noting that the stock outperformed its composite index by 14% in 2009 due to the recovery of the chemical sector.
http://digg.com/u1M2As
No comments:
Post a Comment